![Behzad Aghazadeh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Behzad Aghazadeh
Directeur/Membre du Conseil chez
WHITEHAWK THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Behzad Aghazadeh is currently Director at Aadi Subsidiary, Inc. since 2021, Independent Director at Whitehawk Therapeutics, Inc. since 2021, Director at Scribe Therapeutics, Inc. since 2021, Portfolio Manager & Managing Partner at Avoro Life Sciences Fund LLC, Managing Partner & Portfolio Manager at Avoro Capital Advisor LLC since 2011, and Managing Partner at Avoro Ventures LLC.
Former roles include Executive Chairman at Immunomedics, Inc. from 2019 to 2020, Analyst at AllianceBernstein LP, Analyst at Sio Capital Management LLC, Principal at Strategy&, and Partner at venBio Partners LLC.
Education includes a doctorate from Cornell University conferred in 2000 and a graduate degree from Ludwig-Maximilians-Universität München conferred in 1995.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Behzad Aghazadeh
| Sociétés | Poste | Début |
|---|---|---|
| WHITEHAWK THERAPEUTICS, INC. | Directeur/Membre du Conseil | 26/08/2021 |
Avoro Capital Advisor LLC
 Avoro Capital Advisor LLC Investment ManagersFinance AVCAP aims to achieve attractive returns with moderate risk. The firm invests primarily in the equity, debt and associated derivatives of companies operating in the life sciences sector and related industries with a focus on publicly traded, and late-stage private biotechnology companies. | Gestionnaire de Portefeuille-Actions | 01/07/2011 |
Avoro Life Sciences Fund LLC
 Avoro Life Sciences Fund LLC Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Corporate Officer/Principal | - |
Scribe Therapeutics, Inc.
 Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops CRISPR-based genetic medicines to extend healthy lifespan through disease prevention and durable therapeutic interventions | Directeur/Membre du Conseil | 01/03/2021 |
Aadi Subsidiary, Inc.
 Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Directeur/Membre du Conseil | 01/01/2021 |
Avoro Ventures LLC
 Avoro Ventures LLC Investment ManagersFinance Avoro Ventures invests in public and private companies located in the United States. The firm focuses on life sciences and biotechnology. It participates in seed, early, and late stage transactions. | Private Equity Investor | - |
Anciens postes connus de Behzad Aghazadeh
| Sociétés | Poste | Fin |
|---|---|---|
| IMMUNOMEDICS, INC. | Président | 23/10/2020 |
Strategy&
 Strategy& Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Corporate Officer/Principal | - |
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Private Equity Investor | - |
| ░░░░░░░░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ | - |
Formation de Behzad Aghazadeh
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
78
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Avoro Life Sciences Fund LLC
Avoro Life Sciences Fund LLC Investment Trusts/Mutual FundsMiscellaneous Acts as Hedge Fund | Miscellaneous |
AllianceBernstein LP
 AllianceBernstein LP Investment ManagersFinance AB is a research-driven investment adviser that is global in scope and client-centered in their approach. The firm’s global team of research professionals, whose disciplines include economics, fundamental equity, fixed income and quantitative research, gives them a competitive advantage in achieving investment success for their clients. Within these research disciplines, they also have investment professionals that focus on multi-asset, wealth management and alternative investment strategies. | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ludwig-Maximilians-Universität München
 Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sio Capital Management LLC
 Sio Capital Management LLC Investment ManagersFinance Sio Capital aims to invest capital in a global, healthcare-focused portfolio in order to generate attractive returns for their investors. The firm has a ‘value’ orientation with a strong attention to balance sheet quality and cash flow generation. Their long portfolios typically include growth at a reasonable price (GARP) and growth investments when attractive opportunities arise. For Sio Capital’s portfolios of short investments, they look for shorts that are ‘hyped up’ and whose valuations are predicated on expectations that the firm believes to be unattainable. | Finance |
Strategy&
Strategy& Miscellaneous Commercial ServicesCommercial Services Provides business strategy consulting services | Commercial Services |
venBio Partners LLC
venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Finance |
Avoro Capital Advisor LLC
Avoro Capital Advisor LLC Investment ManagersFinance AVCAP aims to achieve attractive returns with moderate risk. The firm invests primarily in the equity, debt and associated derivatives of companies operating in the life sciences sector and related industries with a focus on publicly traded, and late-stage private biotechnology companies. | Finance |
Aadi Subsidiary, Inc.
Aadi Subsidiary, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Scribe Therapeutics, Inc.
Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops CRISPR-based genetic medicines to extend healthy lifespan through disease prevention and durable therapeutic interventions | Health Technology |
Avoro Ventures LLC
Avoro Ventures LLC Investment ManagersFinance Avoro Ventures invests in public and private companies located in the United States. The firm focuses on life sciences and biotechnology. It participates in seed, early, and late stage transactions. | Finance |
Aadi Bioscience, Inc.
 Aadi Bioscience, Inc. BiotechnologyHealth Technology Develops mTOR inhibitor for targeted patient populations in oncology and cardiovascular diseases | Health Technology |
Choisissez Zonebourse 
